| Verified against primary record | |
| Governing instrument | Lei number 52/2014 of 25 August 2014[3] |
|---|---|
| Data reported to the Commission (2023) | None; Portugal did not submit the questionnaire[1] |
| Statutory monitoring duty | Annual implementation reports by the central administration and the health directorate, published in the first half of the following year[3] |
| Capacity safeguard | Cross-border care in public health service units must not prejudice care for residents[3] |
| Effect of not seeking authorisation | No reimbursement is due[3] |
| Independently reported | |
| Incoming patients under the Directive (2016) | 32,895, the second highest in the European Union[2] |
| Bands apply only to the rows beneath them. Portugal was one of three jurisdictions that did not return the Commission’s questionnaire for reference year 2023, so no current Portuguese claim figures exist in that collection. The Commission’s narrative nonetheless lists Portugal among the more frequent countries of treatment, a figure that cannot be reconciled with the absence of a Portuguese return and is reported here only as an inconsistency in the source. No typical cost range is given because no official Portuguese source publishes prices paid by foreign patients. | |
Medical tourism in Portugal is governed by a statute that is unusually specific about monitoring and unusually specific about protecting domestic patients, and yet Portugal supplied no figures at all to the European Commission for reference year 2023. Portuguese law requires two national bodies to publish annual implementation reports; the Commission records Portugal as one of only three jurisdictions that failed to return its questionnaire. On the most recent comparable measure, from 2016, Portugal was the second largest recipient of incoming cross-border patients in the Union.
A missing return
The Commission received 27 of 30 questionnaires for reference year 2023. Hungary, Portugal and Liechtenstein are recorded as missing. Portugal therefore has no entry in the tables for prior authorisation requests, authorisations, refusals, reimbursement requests or amounts reimbursed.[1]
There is an oddity in the same report. Its narrative text lists Portugal among the more frequent countries of treatment for prior-authorised care, giving a figure of 140, even though Portugal submitted no data. That inconsistency is recorded here because it illustrates how a number can enter circulation from a document whose own tables contain nothing for the country concerned. It should not be treated as a Portuguese statistic.[1]
The Commission does separately name the movement from France to Portugal, alongside France to Spain, as among the busiest reimbursement flows in the Union. That describes French insured persons obtaining care in Portugal and being reimbursed by France, so it appears in the French return rather than in a Portuguese one.[1]
On the earlier and broader measure used by the European Court of Auditors, Portugal received 32,895 incoming patients in 2016, second only to Spain at 46,138 and ahead of Belgium at 27,457, out of a Union total of 213,096 patients of whom 3,562 required prior authorisation.[2]
The Portuguese statute
Portugal transposed the Directive by Lei number 52/2014 of 25 August 2014, published in the first series of the official gazette and approved on 8 July 2014, which also transposes the implementing directive on prescriptions and enters into force on the first working day of the month following publication.[3]
Prior authorisation is required for cross-border surgery needing at least one overnight stay, care using highly specialised and costly equipment, treatments carrying special risk, and care from providers raising serious quality or safety concerns. The consequence of not applying is categorical: where no authorisation request was made, or where it was refused, reimbursement is not due.[3]
Reimbursement extends only to care that the national health service or a regional health service would have covered, and the care must be adequate and scientifically proven. Care not subject to prior authorisation still requires a prior assessment by a public health service family doctor. Payment is capped at the national health service tariff and the applicable medicine co-payment rules and cannot exceed actual costs, with moderating fees and any amount owed by a contractually liable third party deducted.[3]
The statute sets a dense sequence of deadlines: a reimbursement request within 30 days of payment, a clinical assessment within 20 working days, an authorisation reply within 15 working days of the clinical report unless the case is urgent, an opinion from the health directorate within 5 working days, and reimbursement within 90 days of the request, suspended while information is outstanding. Reimbursement claims must carry clinical information coded to an international classification.[3]
The underlying Directive requires the member state of affiliation to reimburse cross-border care where the treatment is among the benefits it covers domestically, capped at the level of costs it would have assumed and not exceeding the actual cost received, and confines prior authorisation to care subject to planning requirements involving an overnight stay or highly specialised and cost-intensive infrastructure, treatments carrying a particular risk, and providers raising serious quality or safety concerns.[5]
Incoming patients and the domestic safeguard
For patients arriving from other member states, the statute requires providers to disclose prices and forbids discrimination on grounds of nationality. It does not set out a charging scheme for such patients in the provisions examined.[3]
It does contain an explicit capacity safeguard: cross-border care delivered in public health service units must not prejudice the care of residents. This is a notable provision, because the question of whether treating foreign patients displaces domestic ones is usually argued in policy rather than settled in statute, and Portugal has answered it in the text of the law.[3]
The national contact point is designated by ministerial order from among the services and bodies of the Ministry of Health, with regional contact points designated by the regional governments. Its duties include informing patients about cross-border care and exchanging information with other member states’ contact points.[3]
The reporting duty that should have produced figures
The statute requires the central health system administration and the health directorate to produce annual monitoring reports on the law’s implementation, to be published during the first half of the following year, with the same duty falling on regional health services. It also requires any restriction on reimbursement to be notified to the European Commission within 30 days, and the list of surgical care requiring authorisation to be notified likewise.[3]
A standing statutory duty to publish annually, set against a missing return to the Commission for reference year 2023, is the central fact about Portuguese cross-border healthcare data. No such annual report was located for this article, and whether any were published is not established here.
Eurostat separately maintains a collection of hospital discharges of non-residents, with tables for in-patients, day cases, bed days and average length of stay, and reports country of residence for non-resident patients where member states can supply it. Individual cell values for Portugal were not retrievable for this article.[4]
Limits of the evidence
Portugal is among the harder European countries to document, not because the legal framework is unclear but because the current figures are absent. The only quantified incoming measure here is from 2016 and comes from an audit report rather than from Portugal. The statute was read from a copy published by a professional body rather than from the official gazette, whose own site could not be rendered, and the law number, date and gazette reference were confirmed from that copy. The provisions summarised are those appearing in the text examined, which may not be the current consolidated version.
See also
- Medical tourism in Spain, the largest recipient on the same 2016 measure
- Medical tourism and health system capacity, the concern Portugal addresses in statute
- Medical tourism in France, the origin of one of the busiest flows into Portugal
- Cross-border healthcare, the framework the missing return belongs to
- Medical tourism statistics, including how figures survive the absence of underlying data
References
- European Commission, Directorate-General for Health and Food Safety. Data on cross-border patient healthcare following Directive 2011/24/EU, reference year 2023. 15 May 2025. Verified against primary record: the report was opened and the record that 27 of 30 questionnaires were received with Hungary, Portugal and Liechtenstein missing, the appearance of a Portuguese figure in the narrative despite the absent return, and the naming of the France to Portugal reimbursement flow were read directly. Retrieved 23 October 2026.
- European Court of Auditors. Special Report 07/2019: EU actions for cross-border healthcare. 2019. Verified against primary record: the report was opened and the 2016 incoming patient figures for Portugal, Spain and Belgium and the Union totals including the prior authorisation count were read. Retrieved 23 October 2026.
- Portuguese Republic. Lei number 52/2014 de 25 de agosto. Diario da Republica, 1st series, number 162. Verified against primary record: the law text was opened and the law number, date and gazette reference, the prior authorisation grounds, the rule that reimbursement is not due without an authorisation request, the reimbursement conditions and caps, the family doctor assessment requirement, the sequence of statutory deadlines, the price disclosure and non-discrimination duties, the safeguard that cross-border care must not prejudice residents, the national and regional contact point designations, and the annual monitoring report duty were read directly. This copy is published by a professional body; the official gazette site could not be rendered. Retrieved 23 October 2026.
- Eurostat. Hospital discharges and length of stay for inpatient and curative care (hlth_hosd), reference metadata. Last updated 15 December 2025. Verified against primary record: the metadata page was opened and the non-resident definition, the statement that country of residence is reported, and the list of non-resident tables were read. Retrieved 23 October 2026.
- European Parliament and Council. Directive 2011/24/EU, Chapter III, Articles 7 and 8. 9 March 2011. Verified against primary record: the chapter text was opened and the reimbursement rule in Article 7 and the three permitted grounds for prior authorisation in Article 8(2) were read. Retrieved 23 October 2026.
Sourcing note: this entry uses only official sources. The figure appearing in the Commission’s narrative for Portugal is reported as an inconsistency within that document rather than as a Portuguese statistic, because Portugal submitted no return for the year in question. No Portuguese annual monitoring report was located, and no claim is made here about whether any were published. The statute was read from a copy published by a professional body because the official gazette page requires client-side rendering; the identifying details were confirmed from the copy itself.